Supernormal vascular aging — prevalence and determinants at population level (the ESSE-RF data)

Background. Arterial stiffness, which is a marker of vascular damage and cardiovascular disease independent predictor, can be used as an indicator of vascular aging. Vascular changes may occur in some individuals earlier than it comes according to chronological age (early vascular aging syndrome) or later (healthy aging). SUPERNOVA (supernormal vascular aging) is a new protective phenotype in which very low arterial stiffness values are recorded regardless of the level of risk factors exposure.

Objective. To assess the prevalence of SUPERNOVA phenomenon and risk factors in St Petersburg population-based sample.

Design and methods. The survey of 1600 St Petersburg residents aged 24-65 years was performed in terms of the epidemiological observation study ESSE-RF (2012-2013). Anthropometry and fasting blood sampling for lipids and glucose detection and blood pressure measurement according to standard methods were performed. Pulse wave velocity (PWV) assessed by SphygmoCor (Australia) was performed in 524 people. 485 participants were selected without cardiovascular complications history. The participants were divided by age into 5 groups: persons under 30 years, 30-39 years, 40-49 years, 50-59 years, 60 years and older. PWV < 10th percentiles for healthy individuals PWV (Reference Values for Arterial Stability’s Collaboration, 2010) was detected as SUPERNOVA phenomenon in each age group. Mathematical and statistical data analysis was implemented using IBM SPSS Statistics 20.0.

Results. SUPERNOVA phenomenon prevalence was 9,8 % (48 participants): 11,9 % women (32 participants) and 7,4 % men (16 participants). Among women systolic blood pressure (SBP) levels (p = 0,01) and body mass index (BMI) (p = 0,055) were significantly lower. Subjects with SUPERNOVA showed significantly lower SBP and diastolic blood pressure (DBP), BMI, glucose, triglycerides and lower prevalence of arterial hypertension (HTN), obesity, hypercholesterolemia and hypertriglyceridemia. In participants younger 30 years only obesity prevalence was significantly lower in respondents with SUPERNOVA, based on BMI criterion (p = 0,046). Participants aged 30-39 years showed no significant differences. In the group aged 40-49 years BMI (p = 0,02), abdominal obesity prevalence (p = 0,05), as well as SBP levels (p = 0,03) and DBP (p = 0,05) was significantly lower in individuals with SUPERNOVA. In the group aged 50-59 with SUPERNOVA significantly lower HTN prevalence (p = 0,03), glucose levels (p = 0,005) and BMI (p = 0,04) were found. In the older age group of 60-65 years subjects with SUPERNOVA have significantly lower levels of SBP (p = 0,014) and DBP (p = 0,014), as well as significantly lower prevalence of HTN (p = 0,03).

Conclusions. At population level the phenomenon of supernormal vascular aging occurs in about 10 % without significant gender prevalence. HTN, obesity and metabolic factors are the determining factors of vascular aging. Ideal vascular health is associated with age-specific features.

1. Laurent S, Marais L, Boutouyrie P. The Noninvasive assessment of vascular aging. Can J Cardiol. 2016;32(5):669-679. doi:10.1016/j.cjca.2016.01.039

2. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318—1327. doi:10.1016/j.jacc.2009.10.061

3. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant metaanalysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636-646. doi:10.1016/j.jacc.2013.09.063

4. Laurent S, Boutouyrie P, Cunha PG, Lacolley Р, Nilsso РМ. Concept of extremes in vascular aging. Hypertension. 2019;74(2):218-228. doi:10.1161/HYPERTENSIONAHA.n9.12655

5. Scientific and organizational committee of the ESSE-RF study: Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Profilak-ticheskaya Meditsina = Russian Journal of Preventive Medicine and Public Health. 2013;16(6):25-34. In Russian.

6. Van Bortel L, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. Hypertension. 2012;30(3):445-448. doi:10.1097/HJH.0b013e32834fa8b0

7. Mattace-Raso F, Hofman A, Verwoert GC, Wittemana JC, Wilkinson I, Cockcroft J et al. Reference values for arterial stiffness collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factor: “Establishing normal and reference values”. Eur Heart J. 2010;31(19):2338—2350. doi:10.1093/eurheartj/ehq165

8. Schellinger I, Mattern K, Raaz U. The Hardest Part. Arterial stiffness in the context of healthy aging. Arterioscler Thromb Vasc Biol. 2019;39:1301-1306. doi:10.1161/ATVBAHA.n8.311578

9. Koivistoinen T, Hutri-Kahonen N, Juonala M, Aatola H, Koobi T, Lehtimaki T et а! Metabolic syndrome in childhood and increased arterial stiffness in adulthood: the Cardiovascular Risk In Young Finns Study. Ann Med. 2011;43(4):312-319. doi:10.3109/07853890.2010.549145

10. Koivistoinen T, Lyytikainen LP, Aatola H, Luukkaala T, Juonala M, Viikari J et al. Pulse wave velocity predicts the progression of blood pressure and development of hypertension in young adults. Hypertension. 2018;71(3):451-456. doi:10.1161/HYPERTENSIONAHA.117.10368

11. Safar M, Asmar R, Benetos A, Blacher J, Boutouyrie P, Lacolley P et al. Interaction between hypertension and arterial stiffness an expert reappraisal. Hypertension. 2018;72(4):796-805. doi:10.1161/HYPERTENSIONAHA.n8.11212

12. Tanaka H, Palta P, Folsom AR, Meyer ML, Matsushita K, Evenson KR et al. Habitual physical activity and central artery stiffening in older adults: the Atherosclerosis Risk in Communities Study. Hypertension. 2018;36(9):1889-1894. doi:10.1097/HJH.0000000000001782

13. Tanaka H. Antiaging effects of aerobic exercise on systemic arteries. Hypertension. 2019;74(2):237-243. doi:10.1161/HYPERTENSIONAHA.119.1317

14. Coutinho T, Borlaug B, Pellikka P, Turner S, Kullo I. Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol. 2013;61(1):96-103. doi:10.1016/j.jacc.2012.08.997